{"id":"https://openalex.org/W7221572012","doi":"https://doi.org/10.25258/ijddt.16.64s.192","title":"QUANTITATIVE ANALYSIS AND VALIDATION OF ELEMENTAL IMPURITIES IN TERAZOSIN ACTIVE PHARMACEUTICAL INGREDIENT USING ICP-MS ACCORDING TO ICH Q3D REQUIREMENTS","display_name":"QUANTITATIVE ANALYSIS AND VALIDATION OF ELEMENTAL IMPURITIES IN TERAZOSIN ACTIVE PHARMACEUTICAL INGREDIENT USING ICP-MS ACCORDING TO ICH Q3D REQUIREMENTS","publication_year":2026,"publication_date":"2026-10-12","ids":{"openalex":"https://openalex.org/W7221572012","doi":"https://doi.org/10.25258/ijddt.16.64s.192"},"language":"en","primary_location":{"id":"doi:10.25258/ijddt.16.64s.192","doi":"https://doi.org/10.25258/ijddt.16.64s.192","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.64s.192","pdf_url":"https://doi.org/10.25258/ijddt.16.64s.192","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.25258/ijddt.16.64s.192","any_repository_has_fulltext":false},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"64s","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10180","display_name":"Analytical chemistry methods development","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/terazosin","display_name":"terazosin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/elemental-impurities","display_name":"elemental impurities","score":0.9210000038146973},{"id":"https://openalex.org/keywords/active-pharmaceutical-ingredients","display_name":"active pharmaceutical ingredients","score":0.8429999947547913},{"id":"https://openalex.org/keywords/icp-ms-method-validation","display_name":"ICP-MS method validation","score":0.8009999990463257},{"id":"https://openalex.org/keywords/ich-q3d","display_name":"ICH Q3D","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pharmaceutical-impurity-analysis","display_name":"pharmaceutical impurity analysis","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.7714999914169312},{"id":"https://openalex.org/C95986675","wikidata":"https://www.wikidata.org/wiki/Q185168","display_name":"Quantitative analysis (chemistry)","level":2,"score":0.6682000160217285},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5641999840736389},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5253999829292297},{"id":"https://openalex.org/C2776679619","wikidata":"https://www.wikidata.org/wiki/Q280786","display_name":"Terazosin","level":3,"score":0.4991999864578247},{"id":"https://openalex.org/C64885871","wikidata":"https://www.wikidata.org/wiki/Q2533665","display_name":"Elemental analysis","level":2,"score":0.47269999980926514},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.3840999901294708},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3749000132083893},{"id":"https://openalex.org/C77170095","wikidata":"https://www.wikidata.org/wiki/Q1753188","display_name":"Linearity","level":2,"score":0.36550000309944153},{"id":"https://openalex.org/C71987851","wikidata":"https://www.wikidata.org/wiki/Q7216430","display_name":"Impurity","level":2,"score":0.3562999963760376},{"id":"https://openalex.org/C106186310","wikidata":"https://www.wikidata.org/wiki/Q1437823","display_name":"Pharmaceutical formulation","level":2,"score":0.3425000011920929},{"id":"https://openalex.org/C2780589914","wikidata":"https://www.wikidata.org/wiki/Q10675206","display_name":"Ingredient","level":2,"score":0.3271999955177307},{"id":"https://openalex.org/C113196181","wikidata":"https://www.wikidata.org/wiki/Q485223","display_name":"Analytical Chemistry (journal)","level":2,"score":0.28200000524520874},{"id":"https://openalex.org/C2984430287","wikidata":"https://www.wikidata.org/wiki/Q186249","display_name":"Pharmaceutical technology","level":2,"score":0.2632000148296356}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25258/ijddt.16.64s.192","doi":"https://doi.org/10.25258/ijddt.16.64s.192","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.64s.192","pdf_url":"https://doi.org/10.25258/ijddt.16.64s.192","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25258/ijddt.16.64s.192","doi":"https://doi.org/10.25258/ijddt.16.64s.192","is_oa":true,"landing_page_url":"https://doi.org/10.25258/ijddt.16.64s.192","pdf_url":"https://doi.org/10.25258/ijddt.16.64s.192","source":{"id":"https://openalex.org/S4210211336","display_name":"International Journal of Drug Delivery Technology","issn_l":"0975-4415","issn":["0975-4415"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Drug Delivery Technology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7221572012.pdf","grobid_xml":"https://content.openalex.org/works/W7221572012.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2647238788","https://openalex.org/W4387389524","https://openalex.org/W3003177997","https://openalex.org/W4366492894","https://openalex.org/W7155601726","https://openalex.org/W3018585134","https://openalex.org/W2801397020","https://openalex.org/W4413001563","https://openalex.org/W4389451786","https://openalex.org/W7223090348"],"abstract_inverted_index":{"Highlights:\u2022":[0],"Developed":[1],"and":[2,29],"validated":[3],"an":[4],"ICP-MS":[5],"method":[6],"for":[7],"Terazosin":[8],"API.\u2022":[9],"Simultaneous":[10],"determination":[11],"of":[12],"seven":[13],"elemental":[14],"impurities.\u2022":[15],"Excellent":[16],"linearity":[17],"achieved":[18],"with":[19,26],"r\u00b2":[20],"values":[21],"above":[22],"0.9986.\u2022":[23],"Method":[24],"complied":[25],"ICH":[27],"Q3D":[28],"USP":[30],"<233>":[31],"requirements.":[32]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-10-13T00:00:00"}